A new Post Doctoral Researcher started at Aston University on the AUTOSTEM project. Dr Panagiota (Naya) Moutsatsou is a chemical engineer by training with extensive lab research experience focusing on nanomedicine, biomaterials and biotechnology. In addition, she possesses experience in Quality Assurance in the food industry. Naya completed her PhD at Loughborough University, UK as part of the EPSRC/MRC Doctoral Training Centre in Regenerative Medicine, where she designed her own polymeric nanofibres by electrospinning to be used for biomedical applications. During her PhD, Naya gained extensive experience of working with biomaterials and mammalian cells and she successfully published her work in two reputable journals.
Orbsen Therapeutics’ AUTOSTEM researcher Eva Camarillo recently defended her PhD thesis at the National University of Ireland Galway. Eva was a Marie Curie ITN Fellow in the DECIDE consortium. The title of Eva’s thesis is, “Bone marrow stromal cell transplantation ameliorates cytopenias caused by depletion of FAP-a expressing cells”. Prior to this, Eva earned her Bachelor of Science degree in Cell Biology from the Universidad Autónoma de Madrid (UAM), in Spain, and a Master of Science in Neuroscience at Freie Universitat Berlin (FU), in Germany. Following on, she simultaneously developed her professional career in several biopharmaceutical companies and public national hospitals in Madrid, Spain. In particular, Eva worked as a specialized laboratory technician in R&D for the Hospital Clínico San Carlos where she characterized the immune response of atherosclerosis in a porcine model. At Mologen S.L., she worked toward developing a DNA vaccine in canine leishmaniosis. In addition, Eva worked on the development of an adipose tissue-derived mesenchymal stem cell therapy for the treatment of complex perianal fistulas associated with Crohn’s disease at Cellerix S.L. (now Tigenix S.L.).